Institution profile

医療法人社団 ICVS Tokyo Clinic V2

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02C2504100 +10

Location

Prefecture
Tokyo
Address
千代田区紀尾井町4番1号 新紀尾井町ビル2F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • ICVS特定認定再生医療等委員会
  • ICVS認定再生医療等委員会

Public score

77.9/ 100

A · Review level
25.0 / 30
B · Technologies
28.6 / 35
C · Coverage
14.3 / 25
D · Class I / II technologies
10.0 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 77.9
Public score →100

Registered technologies (11)

Stem cells (all sources) 9
Registered technologies · Japanese originalTechnology areasPlan classification
慢性閉塞性肺疾患 (COPD:Chronic Obstructive Pulmonary Disease)の治癒を目的とした自己脂肪由来間葉系幹細胞治療Stem cells (all sources)Adipose-derived stem cellsClass II
慢性筋骨格系疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(動脈投与)Stem cells (all sources)Bone marrow-derivedJoints and musculoskeletalClass II
慢性疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(静脈投与)Stem cells (all sources)Bone marrow-derivedClass II
慢性筋骨格系疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(局所投与)Stem cells (all sources)Bone marrow-derivedJoints and musculoskeletalClass II
慢性筋骨格系疼痛の緩和を目的とした自己脂肪由来間葉系幹細胞治療(局所投与)Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
慢性筋骨格系疼痛の緩和を目的とした自己脂肪由来間葉系幹細胞治療(動脈投与)Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
慢性肝障害およびこれに伴う肝線維化または肝硬変の進行抑制・改善を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Stem cells (all sources)Adipose-derived stem cellsClass II
2型糖尿病に伴う血糖コントロールおよび代謝状態の改善を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Stem cells (all sources)Adipose-derived stem cellsClass II
慢性疼痛緩和を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 6
Registered technologies · Japanese originalTechnology areasPlan classification
慢性閉塞性肺疾患 (COPD:Chronic Obstructive Pulmonary Disease)の治癒を目的とした自己脂肪由来間葉系幹細胞治療Stem cells (all sources)Adipose-derived stem cellsClass II
慢性筋骨格系疼痛の緩和を目的とした自己脂肪由来間葉系幹細胞治療(局所投与)Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
慢性筋骨格系疼痛の緩和を目的とした自己脂肪由来間葉系幹細胞治療(動脈投与)Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
慢性肝障害およびこれに伴う肝線維化または肝硬変の進行抑制・改善を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Stem cells (all sources)Adipose-derived stem cellsClass II
2型糖尿病に伴う血糖コントロールおよび代謝状態の改善を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Stem cells (all sources)Adipose-derived stem cellsClass II
慢性疼痛緩和を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Stem cells (all sources)Adipose-derived stem cellsClass II
Bone marrow-derived 3
Registered technologies · Japanese originalTechnology areasPlan classification
慢性筋骨格系疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(動脈投与)Stem cells (all sources)Bone marrow-derivedJoints and musculoskeletalClass II
慢性疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(静脈投与)Stem cells (all sources)Bone marrow-derivedClass II
慢性筋骨格系疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(局所投与)Stem cells (all sources)Bone marrow-derivedJoints and musculoskeletalClass II
NK and immune cells 1
Registered technologies · Japanese originalTechnology areasPlan classification
NK(Natural Killer)細胞療法(予防) (自家培養NK細胞を静脈投与することによりがんの再発およびがんの発症の抑止を期待する細胞療法)NK and immune cellsClass III
Joints and musculoskeletal 4
Registered technologies · Japanese originalTechnology areasPlan classification
慢性筋骨格系疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(動脈投与)Stem cells (all sources)Bone marrow-derivedJoints and musculoskeletalClass II
慢性筋骨格系疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(局所投与)Stem cells (all sources)Bone marrow-derivedJoints and musculoskeletalClass II
慢性筋骨格系疼痛の緩和を目的とした自己脂肪由来間葉系幹細胞治療(局所投与)Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
慢性筋骨格系疼痛の緩和を目的とした自己脂肪由来間葉系幹細胞治療(動脈投与)Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Skin 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己培養線維芽細胞を用いた皮膚の再生治療SkinClass II

Certified committee for regenerative medicine

  • ICVS特定認定再生医療等委員会
  • ICVS認定再生医療等委員会

Public document number

  • 02C2504100
  • 02C2508027
  • 02C2508044
  • 02C2508046
  • 02C2508059
  • 02C2605032
  • 02C2605078
  • 01C2605054
  • 01C2606019
  • 02C2609018
  • 02C2604001
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
慢性閉塞性肺疾患 (COPD:Chronic Obstructive Pulmonary Disease)の治癒を目的とした自己脂肪由来間葉系幹細胞治療Class IIICVS特定認定再生医療等委員会02C2504100
慢性筋骨格系疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(動脈投与)Class IIICVS特定認定再生医療等委員会02C2508027
慢性疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(静脈投与)Class IIICVS特定認定再生医療等委員会02C2508044
慢性筋骨格系疼痛緩和を目的とした自己骨髄由来間葉系幹細胞治療(局所投与)Class IIICVS特定認定再生医療等委員会02C2508046
自己培養線維芽細胞を用いた皮膚の再生治療Class IIICVS特定認定再生医療等委員会02C2508059
慢性筋骨格系疼痛の緩和を目的とした自己脂肪由来間葉系幹細胞治療(局所投与)Class IIICVS特定認定再生医療等委員会02C2605032
慢性筋骨格系疼痛の緩和を目的とした自己脂肪由来間葉系幹細胞治療(動脈投与)Class IIICVS特定認定再生医療等委員会02C2605078
慢性肝障害およびこれに伴う肝線維化または肝硬変の進行抑制・改善を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Class IIICVS特定認定再生医療等委員会01C2605054
2型糖尿病に伴う血糖コントロールおよび代謝状態の改善を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Class IIICVS特定認定再生医療等委員会01C2606019
慢性疼痛緩和を目的とした自己脂肪由来間葉系幹細胞治療(静脈投与)Class IIICVS特定認定再生医療等委員会02C2609018
NK(Natural Killer)細胞療法(予防) (自家培養NK細胞を静脈投与することによりがんの再発およびがんの発症の抑止を期待する細胞療法)Class IIIICVS認定再生医療等委員会02C2604001

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor